AIMC Topic: Chromogranin A

Clear Filters Showing 1 to 2 of 2 articles

Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role.

Atherosclerosis Dec 24, 2018
BACKGROUND AND AIMS: The neuropeptide catestatin (CST) is an endogenous nicotinic cholinergic antagonist that acts as pleiotropic cardiac protective hormone. This study investigated the association between CST and coronary artery disease (CAD) and th...
Humans Cells, Cultured Cytokines Biomarkers Female Animals Male Severity of Illness Index Case-Control Studies Disease Models, Animal Human Umbilical Vein Endothelial Cells Peptide Fragments Anti-Inflammatory Agents Coronary Artery Disease Atherosclerosis Down-Regulation Cell Adhesion Molecules Angiotensin-Converting Enzyme 2 Chromogranin A Mice, Knockout, ApoE Peptidyl-Dipeptidase A Plaque, Atherosclerotic
View on PubMed DOI

Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm.

The Journal of surgical research Dec 29, 2016
BACKGROUND: Small pancreatic neuroendocrine tumors (PNETs) are a unique subset of pancreatic neoplasms. Chromogranin A (CgA) levels, mitotic rate, and histologic differentiation are often used to characterize PNET behavior. This study evaluates the i...
Humans Databases, Factual Prognosis Retrospective Studies Female Aged Aged, 80 and over Young Adult Adult Biomarkers, Tumor Male Middle Aged Adolescent Logistic Models Pancreatic Neoplasms Cell Differentiation Neoplasm Staging Survival Analysis Multivariate Analysis Propensity Score Chromogranin A Mitosis Neuroendocrine Tumors
View on PubMed DOI
Popular Topics
Recent Journals